CompletedPhase 1NCT03572530

Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma

Studying Ependymoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The University of Texas Health Science Center, Houston
Principal Investigator
David I Sandberg, MD
The University of Texas Health Science Center, Houston
Intervention
5-Azacytidine (5-AZA) group 1(drug)
Enrollment
3 enrolled
Eligibility
1-80 years · All sexes
Timeline
20192020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03572530 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma

← Back to all trials